Jaber B M, Mukopadhyay R, Smith C L
Molecular and Cellular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030, USA.
J Mol Endocrinol. 2004 Feb;32(1):307-23. doi: 10.1677/jme.0.0320307.
The p160 coactivators, steroid receptor coactivator-1 (SRC-1), transcriptional intermediary factor-2 (TIF2) and receptor-associated coactivator-3 (RAC3), as well as the coactivator/integrator CBP, mediate estrogen receptor-alpha (ERalpha)-dependent gene expression. Although these coactivators are widely expressed, ERalpha transcriptional activity is cell-type dependent. In this study, we investigated ERalpha interaction with p160 coactivators and CBP in HeLa and HepG2 cell lines. Basal and estradiol (E2)-dependent interactions between the ERalpha ligand-binding domain (LBD) and SRC-1, TIF2 or RAC3 were observed in HeLa and HepG2 cells. The extents of hormone-dependent interactions were similar and interactions between each of the p160 coactivators and the ERalpha LBD were not enhanced by 4-hydroxytamoxifen in either cell type. In contrast to the situation for p160 coactivators, E2-dependent interaction of the ERalpha LBD with CBP or p300 was detected in HeLa but not HepG2 cells by mammalian two-hybrid and coimmunoprecipitation assays, indicating that the cellular environment modulates ERalpha-CBP/p300 interaction. Furthermore, interactions between CBP and p160 coactivators are much more robust in HeLa than HepG2 cells suggesting that poor CBP-p160 interactions are insufficient to support ERalpha-CBP-p160 ternary complexes important for nuclear receptor-CBP interactions. Alterations in p160 coactivators or CBP expression between these two cell types did not account for differences in ERalpha-p160-CBP interactions. Taken together, these data revealed the influence of cellular environment on ERalpha-CBP/p300 interactions, as well as CBP-p160 coactivator binding, and suggest that these differences may contribute to the cell specificity of ERalpha-dependent gene expression.
p160共激活因子,即类固醇受体共激活因子-1(SRC-1)、转录中介因子-2(TIF2)和受体相关共激活因子-3(RAC3),以及共激活因子/整合因子CBP,介导雌激素受体α(ERα)依赖性基因表达。尽管这些共激活因子广泛表达,但ERα转录活性具有细胞类型依赖性。在本研究中,我们调查了HeLa和HepG2细胞系中ERα与p160共激活因子及CBP的相互作用。在HeLa和HepG2细胞中观察到ERα配体结合域(LBD)与SRC-1、TIF2或RAC3之间的基础及雌二醇(E2)依赖性相互作用。激素依赖性相互作用的程度相似,且在两种细胞类型中,4-羟基他莫昔芬均未增强p160共激活因子与ERα LBD之间的相互作用。与p160共激活因子的情况相反,通过哺乳动物双杂交和免疫共沉淀试验在HeLa细胞中检测到ERα LBD与CBP或p300的E2依赖性相互作用,而在HepG2细胞中未检测到,这表明细胞环境调节ERα-CBP/p300相互作用。此外,CBP与p160共激活因子之间的相互作用在HeLa细胞中比在HepG2细胞中更强,这表明CBP-p160相互作用较弱不足以支持对核受体-CBP相互作用很重要的ERα-CBP-p160三元复合物。这两种细胞类型之间p160共激活因子或CBP表达的改变并不能解释ERα-p160-CBP相互作用的差异。综上所述,这些数据揭示了细胞环境对ERα-CBP/p300相互作用以及CBP-p160共激活因子结合的影响,并表明这些差异可能导致ERα依赖性基因表达的细胞特异性。